AIM ImmunoTech Inc. · AMEX:AIM

Equels Thomas K bought 20,299 AIM ImmunoTech Inc. shares (Form 4)

Traded Nov 6, 2026 · Filed Nov 6, 2026

On Nov 6, 2026, Equels Thomas K (Director, CEO & President) bought 20,299 AIM ImmunoTech Inc. shares at US$0.16 for US$3,167, leaving 210,046 shares. Filed Nov 6, 2026 (Form 4).

Bought
20,299 shares
Price
US$0.16
Value
US$3,167
Holding after
210,046 shares
Trading plan
No
Role
Director, CEO & President

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 6, 2026Common StockBuy20,299US$0.16210,046Direct

Source

Download original · View original at SEC

Related